Table 4

Clinical data and molecular sub-type of primary MB specimens utilised in this investigation
Sample Gender Age M Status Sub-type
M2 Female 3 Unknown B
M6 Male 7 M+ C
M7 Male 1.5 M0 B
M9 Male 2 Unknown N/A
M11 Male 5 M+ DE
M14 Female 3 M0 C
M15 Male 3 M+ DE
M17 Male 4 M+ DE
M22 Male 1 Unknown N/A

Metastatic status was defined as M0 (no metastasis) or M + (distant metastases). Primary specimens defined as “N/A” were not available for sub-typing analysis [47]. Sub-type designations were based on the data of Kool et al., [3].

Genovesi et al.

Genovesi et al. BMC Research Notes 2012 5:507   doi:10.1186/1756-0500-5-507

Open Data